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Abstract 
Weight control through either dietary calorie restriction (DCR) or exercise is associated 
with cancer prevention in animal models. However, the underlying mechanisms are not fully 
defined. Bioinformatics approaches using genomics, proteomics, and lipidomics were employed 
to elucidate the profiling changes of genes, proteins, and phospholipids in response to weight 
loss by DCR or exercise in a mouse skin cancer model. SENCAR mice were randomly assigned 
into 4 groups for 10 weeks: ad lib-fed sedentary control, ad lib-fed exercise (AE), exercise but 
pair-fed isocaloric amount of control (PE), and 20% DCR. Two hours after topical TPA 
treatment, skin epidermis was analyzed by Affymetrix for gene expression, DIGE for 
proteomics, and lipidomics for phospholipids. Body weights were significantly reduced in both 
DCR and PE but not AE mice versus the control. Among 39,000 transcripts, 411, 67, and 110 
genes were significantly changed in DCR, PE, and AE, respectively. The expression of genes 
relevant to PI3K-Akt and Ras-MAPK signaling was effectively reduced by DCR and PE as 
measured through GenMAPP software. Proteomics analysis identified ~120 proteins, with 22 
proteins significantly changed by DCR, including upregulated apolipoprotein A-1, a key 
antioxidant protein that decreases Ras-MAPK activity. Of the total 338 phospholipids analyzed 
by lipidomics, 57 decreased by PE including 5 phophatidylinositol species that serve as PI3K 
substrates. Although there were many impacts that we still need to characterize, it appears that 
both Ras-MAPK and PI3K-Akt signaling pathways are the key cancer preventive targets that 
have been consistently demonstrated by three bioinformatics approaches.  
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Chapter 1 - Review of Literature  
 Obesity Epidemic  
Rising rates of obesity both in the developed and developing world due to increased 
caloric intake and/or sedentary lifestyles has placed a major burden on healthcare systems. With 
obesity rates of greater than one-third for adults and 17% for children in the US in 2009-2010, 
strategies need to be further developed to stabilize and lower these rates.
1
 Obesity is a 
contributing factor for many chronic diseases such as cardiovascular diseases, diabetes, and 
many types of cancer,
2,3
 and it has been associated with increased risk for colorectal, breast, 
endometrial, kidney, esophageal, pancreatic, prostate, and liver cancer.
4
 Obesity has also been 
shown to greatly increase the risk for mortality due to cancer.
3
 Tannenbaum demonstrated that 
calorie restriction reduced spontaneous and chemically induced tumors in several mouse or 
rodent models, demonstrating a direct cancer preventive effect of calorie restriction.
5
 Body 
weight control, through both dietary calorie restriction and exercise, has been identified as a 
possible preventive means to reduce cancer due to obesity.  
Many mechanisms have been studies to better understand the role of obesity in cancer 
etiology. Growth hormones such as IGF-1 and insulin have been shown to increase in obese mice 
with possible cancer promotion. Excess body fat from obesity can further lead to production of 
adipokines such as leptin that have been correlated with increased cancer rates. Inflammatory 
cytokines also seem to be increased with obesity. Increased oxidation and inflammatory response 
are other possible changes due to obesity that may promote cancer.
6
 Many cellular signaling 
pathways have been investigated to better understand the etiology of obesity and cancer. As the 
etiology of weight control to prevent cancer still remains unclear, further investigation is 
warranted. 
 Dietary Calorie Restriction for Cancer Prevention 
 
 History of Calorie Restriction in Mice  
Dietary calorie restriction (DCR) consists of restricting total caloric intake while 
adequate protein and micronutrient levels. DCR is oftentimes called “undernutrition without 
malnutrition.” Caloric restriction typically reduces total calories at 20-40% restriction levels.7 
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Moreschi et al. first performed calorie restriction studies in mice in 1909, noting that caloric 
restriction reduced tumor growth rate.
8
 Tannenbaum in 1940 noted that DCR also decreased the 
number of spontaneous and chemically-induced tumors in mice.
5
 Subsequent rodent studies have 
confirmed that reduction in caloric intake decreases tumor rates.
9
 DCR has been shown to 
decrease cancers such as mammary, skin, colon, pancreas, and leukemia,
10
 and it has been 
identified as the most potent and effective dietary treatment for cancer prevention.
7
 While a 
strong relationship has been established for DCR and cancer prevention, the molecular 
mechanisms remain unclear.
10
 
 Molecular Targets of Dietary Calorie Restriction and Cancer Prevention 
This clear relationship between calorie restriction and decreased cancer rates has led 
researchers to search for specific molecular pathways by which DCR causes cancer prevention. 
Some possible mechanisms by which DCR prevents cancer could include DNA repair, 
antioxidant activity, apoptosis promotion, and inhibition of cellular proliferation. Nuclear factor 
(erythroid-derived 2) 45kDa (NF-E2) pathway induces antioxidant activity, and its levels have 
been increased by calorie restriction.
11
 Anti-inflammation is another possible cancer prevention, 
and peroxisome proliferator-activated receptor-gamma (PPAR-γ) is a possible DNA repair 
protein seen in calorie restriction for anti-inflammation.
12
 Additionally, cancer is induced by 
cellular pathways that promote cellular proliferation and anti-apoptosis activity. One possible 
key target is the Phosphatidylinositide 3-kinase/Protein Kinase B/mammalian target of 
rapamycin (PI3K-Akt-mTOR) towards cell growth and inhibition of apoptosis.
13
 Some possible 
downstream activity related to cancer could include Forkhead box protein O (FOXO), mTOR-S6 
kinase, AMP-activated protein kinase (AMPK), Glycogen synthase kinase 3 beta (GSK-3β), 
silent mating type information regulation 2 homolog 1 (SIRT-1) and Signal transducer and 
activator of transcription 3 (STAT 3).
13-15
 FOXO pathway is believed to promote apoptosis 
through acting as transcription factor for ricin to exit the G1-S phase of cell cycle. Meanwhile, 
mTOR-S6 in a downstream pathway of PI3K-Akt that is believed to promote anti-apoptosis 
activity.
16
 AMPK has a possible cancer preventive effect through reducing anti-apoptosis 
signaling form PI3K-Akt.
17
 GSK-3β is a downstream enzyme that promotes anti-apoptosis.14 
STAT 3 is DNA binding protein that is highly phosphorylated in cells with cancer, and it also is 
affected by PI3K-Akt activity.
15,18
 A transgenic mouse with knock-in SIRT1 genes showed 
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similar phenotypes to DCR mice such as reduced body weight, increased insulin sensitivity, 
decreased adipokine levels, and increased metabolism through gluconeogenesis.
19
 The SIRT1-
FOXO3 pathway also has been shown to increase renal cell autophagy in an induced-hypoxia 
model.
20
  Further important mechanisms for SIRT1-FOXO3 and cancer prevention include 
increased DNA repair, cell cycle arrest, and reduction of oxidative stress.
21 
The Ras/MAPK/ERK 
is another pathway that leads to cancer promotion. Higher levels of IGF-1 and insulin have been 
seen in obese mice with a corresponding increase in PI3K-Akt activity. Many of the pathways 
are complicated and are interconnected through crosstalk, and a more global approach using 
bioinformatics could help better elucidate the key biochemical pathways of weight control for 
cancer prevention.   
 Dietary Calorie Restriction and Clinical Trials 
Many epidemiological studies have shown a relationship between decreased caloric 
intake and prevention of chronic disease. Older natives Okinawa islands of Japan who 
traditionally eat a lower calorie diet compared to the general Japanese population are expected to 
live approximately 5% longer and demonstrate decreased cardiovascular-related deaths.
22
 
Following a famine in the Norway during World War II, records have shown decreased deaths 
from cancer and other chronic diseases due to caloric restriction.
23,24
 Western diet, containing 
more energy dense foods, is associated with higher rates of colon cancer; migrants from Japan to 
the United States have demonstrated this relationship of Western diet and increased colon cancer 
risk.
25
 Thus, it appears that epidemiological studies point to calorie restriction as an effective 
treatment for the prevention of chronic diseases such as cancer.  
Dietary Calorie Restriction (DCR) has a strong history in reducing cancer rates and 
improving longevity in a variety of animal and cell culture models. In the late 1980s, DCR 
studies in rhesus monkeys to have a DCR animal model in a species closer to humans. Recent 
studies have shown that DCR in monkeys does reduce cancer rates and improves HDL 
cholesterol. Within the past ten years studies have been conducted to analyze the effectiveness of 
DCR in human clinical trials. In 2008, Fontana et al. reported that 25% DCR for one year did not 
reduce IGF-1 levels unless it was accompanied with protein restriction. Thus, it appears that 
protein restriction could have a major role in providing DCR benefits.
26
 Further studies are 
currently being undertaken to measure the effectiveness of DCR in humans. 
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 Dietary Calorie Restriction Mimetics 
With the variety of pathways identified for DCR and cancer, many pharmalogical 
interventions have been conducted to mimic the effect of DCR on cancer pathways. Higher 
levels of insulin have been identified with increased risk for cancer, and insulin sensitizers could 
improve cancer profile. Metformin is a drug currently accepted for treatment of type II diabetes 
through improving insulin sensitivity, and its use could also protect against cancer through 
means similar to DCR’s insulin sensitivity effect. SIRT-1 and PPAR-γ may also be used to 
improve the lipid profile through reducing lipid accumulation in adipocytes. Reduction of fat 
could reduce adipokines and hormones related to obesity that increase cancer. Increased 
adiponectin has been shown to reduce body weight and increase insulin sensitivity, and 
adiponectin therapy is another possible DCR mimetic that could prevent cancer. Finally, there 
are a number of foods that could prevent IGF-1 including: retinoids, soy isoflavones, and 
flavonoids.
27
  
 
 Exercise for Cancer Prevention 
 Relationship of Exercise to Dietary Calorie Restriction for Cancer Prevention 
Exercise is another form of weight control that has been studied for its possible cancer 
prevention similar to DCR. In humans, long-term exercise has been associated with a decreased 
risk for cancers such as endometrial and colon cancer.
28,29
 In a review on physical activity and 
cancer, Friedenriech et al. noted that cancer prevention was: convincing and/or probable for 
colon, breast and endometrial cancers; possibly associated with lung, prostate, and ovarian 
cancers; and insufficiently supported for other cancers such as leukemia, gastric, kidney, and 
cervical cancers.
30  
 
While exercise does have a positive health benefit to many chronic diseases, its 
effectiveness for cancer prevention still remains unclear. Voluntary wheel running exercise has 
been shown to decrease tumor size in mouse skin cancer models.
31,32
 Moore et al. noted that 
exercise alone does not decrease intestinal polyps in APC
Min
 mice,
33
 similar to our findings that 
exercise needs to be in conjunction with isocaloric intake for cancer prevention.
34
 The impact of 
exercise on physical activity seems positive, but it is not as consistent as DCR.
10
 It appears that 
negative energy balance plays a key role in exercise for cancer prevention. 
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 Biological Targets of Exercise for Cancer Prevention 
Examining potential targets for exercise on cancer prevention is helpful in understanding 
its possible relationship with DCR in cancer prevention. Friedenreich et al. noted that probable 
biological mechanism for physical activity and cancer prevention included: decreased body fat, 
decreased insulin resistance, improved pulmonary function, and decreased sexual hormone 
activity; meanwhile, evidence was more limited for physical activity and biological mechanisms 
such as: increased vitamin D levels, decreased IGF-1 levels, decreased adipokines such as leptin 
and Interleukin 6 (IL-6), decreased inflammation, improved immune function, and increased 
antioxidant activity.
30
 Further study examining both DCR and physical activity is necessary to 
better understand the complex mechanisms of weight control for cancer prevention. 
 Physical Activity and Clinical Trials 
According to the American Cancer Society, regular exercise may reduce the risk for 
colon, breast, endometrial cancers, and possibly late-stage prostate and pancreatic cancers. 
Possible mechanisms for physical activity and cancer prevention include: reduction of oxidation, 
enhanced DNA repair, suppressed proliferation, increased apoptosis, decreased inflammation, 
and induction of differentiation.
35
 For colon cancer, physical 30-60 minutes of moderate to 
vigorous exercise per day is associated with a 30-40% reduction in colon cancer risk. It appears 
that modulation of insulin and IGF-1 pathways, improved antioxidant activity, and decreased 
transit time are the major biological mechanisms for cancer prevention through physical 
activity.
36
 Physical activity has also been shown to lower breast cancer and increase breast 
cancer survivor rates. Physical activity of 2-3 hours per week was shown to reduce insulin and 
IGF-1 levels to prevent breast cancer.
37
 Physical activity is thought to have a protective effect of 
prostate cancer through decreasing IGF-1 levels, improved immunity, and antioxidant activity.
38
 
Many studies are continuing to examine the possible effect of physical activity on other cancers 
in humans. Additionally, many studies have shown an improved survival rate for cancer patients 
who incorporate an exercise routine in recovery following surgery or chemotherapy.
39
 Further 
studies need to be done to determine the effectiveness and chemical pathways through which 
physical activity reduces cancer. 
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 Hormones Related to Weight Control and Cancer Prevention 
 IGF-1 and Insulin 
Insulin-like growth factor-1 (IGF-1) is an endocrine hormone secreted by the liver that 
has similarities with insulin, and it is stimulated by Growth Hormone (GH). IGF-1 can bind to 
six homologues of IGF-1 binding proteins (IGF-BP’s) on the IGF-1 receptor, in addition to its 
ability to bind to insulin receptor.
40
 Binding of IGF-1 to its receptor modulates downstream 
activity of PI3K-Akt and Ras-MAPK, both key cancer pathways for anti-apoptosis and cell 
proliferation respectively.
41
 
IGF-1 serum levels in humans have increased risk for certain cancers such as breast, 
prostate, colon, and lung cancers.
42
 Transgenic mice (HK1.IGF-1) with increased IGF-1 
production experienced more rapidly growing tumors and increased number of tumors in a 
chemically-induced cancer model.
43
 DCR has been shown to decrease IGF-1 levels in 
animals.
23,44
 Injection of IGF-1 into DCR mice has been shown to reverse the cancer protective 
effect as seen in our lab and others.
45,46
 Further, our lab has shown that exercise with isocaloric 
intake, but not ad libitum exercise, also decreases plasma levels of IGF-1.
34
 Thus, it appears that 
negative energy balance modulates decreased IGF-1 levels for possible cancer prevention.      
Insulin is also an important growth factor that could be related to weight control for 
cancer prevention. Higher insulin levels and insulin resistance are characteristic of type 2 
diabetes and obesity. Insulin and IGF-1 are both raised in obese individuals, and they lead to 
increased signaling through the PI3K-Akt pathway towards anti-apoptosis.
33,47
 Negative energy 
balance through both DCR and exercise is a strong possible protection against cancer promotion 
from growth factors like IGF-1 and insulin. 
 Adipokines: Leptin and Adiponectin 
Leptin and adiponectin are adipokines that are secreted by adipose tissue for endocrine 
function. Leptin regulates appetite and body weight through feedback with the hypothalamus.
48
 
High plasma levels of leptin have been associated with increased risk for cancer. Leptin is 
correlated with amount of body fat, and leptin is primarily secreted by adipocytes. Leptin 
receptor activation leads to pro-cancer pathways including: Ras-MAPK, PI3K-Akt, PKC-p38 
kinase, and AP-1 transcription factors.
10,49-50 
(Garofalo 2006, Fruhbeck 2006). Studies have been 
conducted demonstrating a similar cancer promoting effect of leptin and IGF-1, indicating that 
7 
 
they may work together in cancer promotion. Studies from our lab have shown that weight 
control modulates a decrease in leptin. Adiponectin has an inverse relationship with cancer risk. 
Adiponectin has been shown to increase insulin sensitivity and decrease body weight. Lower 
levels of adiponectin have been associated with increased risk for breast, prostate, and colon 
cancers.
10
 
 Glucocorticoids 
Glucocorticoid levels have been shown to increase in DCR animals, and increased 
glucocorticoid levels is thought to lead to cancer prevention. A diet with increased corticosterone 
led to decreased in mammary tumors in a rat model. Further, adrenalectomy reversed the cancer 
preventive effect of corticosteroid levels in DCR mice in SENCAR mice.
10
 Glucocorticoid levels 
may be responsible for possible cancer prevention.  
 
 Conclusion 
Weight control through both DCR and exercise show strong cancer preventive effects in 
both animal studies and human clinical trials. Obesity has been identified as a risk factor for 
cancer, but its mechanism of cancer promotion is unclear. Animal models, especially normal 
weight models, demonstrate weight-loss induced cancer prevention. Findings from these studies 
may provide potential mechanisms for future understanding of obesity and cancer. There are 
many different cancer pathways related to obesity and cancer promotion, so further analysis is 
needed to better understand the best pathways to identify to focus for cancer preventive 
measures. Traditional techniques have isolated specific targets to better understand cancer 
pathways. Bioinformatics tools have been developed within the past decade to better understand 
a global approach to pathways related to diseases such as cancer. Our study is looking to identify 
major cancer pathways through analyzing global studies of genes, proteins, and lipids using 
bioinformatics techniques of microarray analysis, proteomics, and lipidomics to better 
understand the etiology of weight control for cancer prevention.  
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Chapter 2 - Both PI3K-AKT and RAS-MAPK Are the Key 
Signaling Targets for Weight Loss-Induced Cancer Preventive 
Mechanisms by Dietary Calorie Restriction or Physical Activity 
 Introduction 
Obesity has been identified as risk factor for many chronic diseases including cancer. 
Since 1960, obesity rates have doubled in US men and nearly tripled in US women, with both 
groups at rates over 30%.
1,2
 Obesity and overweightness contribute to cancer deaths in up to 14% 
for men and 20% for women over age 50, with higher rates of mortality for overweight cancer 
patients.
3
 With rising rates of obesity and chronic diseases, many studies have focused on various 
interventions to prevent obesity-related chronic diseases. In the early 20th century, dietary 
calorie restriction (DCR) was shown to prevent tumor growth in animal models. Since then, it 
has been the most robust nutritional intervention for cancer prevention. As sedentary behavior 
has become endemic worldwide, exercise has been also identified as another lifestyle behavior 
that could reduce body weight and chronic disease risk. Weight control through DCR and/or 
exercise may be responsible, at least in animal models, for cancer prevention.  
DCR is a weight control measure that decreases caloric intake of fats and carbohydrates 
while maintaining protein, fiber, and micronutrients. Typical studies have withheld calories 
between 20 and 40%.
4
 After a pilot study in 1909 by Moreschi, DCR has been shown to prevent 
cancer in a variety of animal models and to be effective in reducing both chemically induced and 
spontaneous tumors.
5
 On the other side, increased energy expenditure through exercise is another 
form of weight control that may contribute to cancer prevention. Exercise has been strongly 
associated with cardiovascular health benefits, but the cancer preventive effect of exercise is less 
consistent. Exercise has demonstrated convincing evidence for cancer prevention in colorectal
6
 
and breast cancer.
7
 Additionally, exercise is probable for prostate cancer prevention, and it is 
possible for endometrial and lung cancer prevention.
8
 Voluntary wheel running exercise 
provided cancer prevention by decreasing tumor size in a mouse skin cancer model.
9,10 
Some 
studies, however, have shown that exercise may not protect against cancer.
11-13
 Furthermore, 
previous studies in our lab had mixed results of exercise for cancer prevention, with protection 
only seen with iso-caloric intake.
14
 Moore et al. demonstrated that a negative energy balance as 
14 
 
opposed to exercise alone was responsible for inhibiting intestinal polyps in APC
Min
 mice.
15
 
Thus, our study compared exercised mice with or without iso-caloric intake. 
A variety of studies have been conducted to discover the biological mechanisms of 
weight control for cancer prevention. Many studies have focused on endocrine hormones and 
adipokines that are modified by increased adiposity. IGF-1 is a growth factor that has been 
widely studied for cancer promotion. Increased IGF-1 levels from obesity have been associated 
with increased cancer risks. IGF-1 receptor has been shown to activate downstream pathways 
such as: MAPK towards increased proliferation, PI3K-Akt towards anti-apoptosis and increased 
protein synthesis, and JAK/STAT for gene transcription of IGF-1 receptor.
16-17
 In addition, 
adipocyte-secreted adipokines such as leptin have been shown to promote pro-cancer cellular 
signaling.
18-19
  
While traditional studies have been limited to examining a few select genes, proteins, or 
fat signaling phospholipids of interest to gauge the cancer preventive effect of weight control, 
recently developed -omics tools have enabled us to employ a more global approach to examine 
the etiology of cancer development. Genomics, proteomics, and lipidomics are -omics tools that 
examine the interplay of profiling changes of genes, proteins, and phospholipids on the 
development of cancer. We hypothesized that application of genomics, proteomics, and 
lipidomics in this study may provide new information of a mechanistic understanding of cancer 
prevention by weight control. 
 Methods and Materials 
 Animals and Treatment 
Six-week-old female SENCAR mice were purchased from NIH (Frederick, MD). Mice 
underwent a two-week training period to adjust to the new environment and treadmill exercise. 
Mice were housed individually at 24 ± 1 ˚C with a 12:12 light-dark cycle and given water ad 
libitum. Mice were divided into four treatment groups consisting of sedentary ad libitum-fed 
controls (control), ad-libitum-fed exercise (AE), pair-fed exercise (PE), and 20% DCR.  Ad 
libitum controls and ad libitum exercise mice were allowed to freely access food, while the pair-
fed exercise group was match-fed to the control’s consumption. The basal AIN-93 and 20% 
DCR diets were made by Harland Teklad (Madison, WI). The 20% DCR diet that withheld 
calories from fat and carbohydrate is shown in Table 2.1 (see next page). A speed adjustable 
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rodent treadmill (Boston Gears, Boston, MA) was used for mice in exercise treatment groups. 
After two weeks training, the exercise groups ran on the treadmill at 13.4 m/min, 60 min per day 
and 5 days a week for 10 weeks. This exercise level has been rated as moderate intensity.
20
 
Weekly body weights and food consumption measurements were taken. 
At the end of the experiment, mice were sacrificed and the dorsal skin samples were 
snap-frozen in liquid nitrogen and stored at -70 ˚C until further analyses. 
Table 2.1 Experimental Diet Composition 
 
a
AIN-93 custom made diet by Harlan Teklad (Madison, WI)  
b
DCR mice were fed 0.82 g of diet for every gram consumed by control mice  
c
Dietary calorie restriction from fat source 
d
Dietary calorie restriction from carbohydrate source 
 
 Microarray Analysis 
 Microarray analysis was performed as described in our previous studies.14,21 Briefly, labeled 
cRNA was applied to an Affymetrix GeneChip Mouse Genome 430 2.0 Array containing 39,000 
transcripts and 45,101 probe sets (Santa Clara, CA). The images were quantified by using 
GeneChip operating software 1.0 (GCOS 1.0; Affymetrix, Santa Clara, CA). The raw image 
readings were analyzed using Simpleaffy package from BioConductor at 
http://www.bioconductor.org. The data were normalized using either MAS or RMA algorithms. 
The genes that were differentially expressed between treatment groups were identified by using 
Diet Components
a
 Control Diet 20% DCR
b
 
Corn Oil 5.0 3.7
c
 
Casein 20.0 20.0 
DL Methionine 0.3 0.3 
Dextrose 15.0 12.3
d
 
Dextrin 49.9 37.1
d
 
Fiber 5.0 5.0 
AIN-93 Mineral Mix 3.5 3.5 
AIN-93 Vitamin Mix 1.0 1.0 
Choline bitartrate 0.25 0.25 
Total amount of food 100.0 82.0 
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pair wise comparison. The data were filtered by using 1.5-fold difference and a p-value less than 
0.05 as a cutoff. 
Cytoscape v2.6.0 coupled with plug-in BiNGO v2.0 was used to map the predominant 
gene ontology categories of the differentially expressed genes.
22
 The GO annotations p-values 
were obtained by hypergeometric statistical test for cluster verse whole annotation. The test was 
adjusted by Benjamin and Hochberg false discovery rate, which is included in the BiNGO 
package. The dataset consisting of the significantly altered genes was loaded into GenMAPP2.0 
(Gene Map Annotator and Pathway Profiler, www.genmapp.org) to analyze the effect of target 
gene expression on specific pathways. As reported previously,
14,22
 RT-PCR on select genes was 
tested to confirm the microarray results (data not shown). 
 Proteomics Analysis 
 Mouse skin tissues were homogenized, and the protein concentration was determined by 
utilizing Protein RC DC assay (Bio-Rad, Hercules, CA). The protein lysis was purified by 
ReadyPrep 2-D cleanup kit (Bio-Rad, Hercules, CA). The spots of interest were excised and 
subjected to in-gel digestion using proteomics grade trypsin (Sigma, St Louis, MO). The digested 
peptides were analyzed on a MALDI TOF/TOF instrument (Bruker, MA) using α-cyano-4-
hydroxycinnamic acid (Sigma, St. Louis, MO) as matrix. Peak annotation was carried out 
automatically using software Proteinscape supplied by the instrument manufacturer 
(Bruker,MA). The m/z-lists were submitted to MASCOT to search the NCBI protein sequence 
database. 
Sample labeling with cyanine minimal dyes was carried out according to the 
manufacturer’s instructions (GE healthcare, Piscataway, NJ). Protein (25 μg) was used for 
CyDye labeling and the ratio of protein to CyDye is 1 μg protein: 5 pmol CyDye. The internal 
standard was always labeled with cy2, and the samples were labeled with Cy3 and Cy5 
alternatively. The isoelectric focusing was carried on a PROTEAN IEF Cell following 
manufacture’s instruction (Bio-Rad, Hercules, CA). SDS PAGE was conducted using a precast 
8-20% gradient gel (Bio-Rad, Hercules, CA). After running, the gels with Cydye labeled proteins 
were scanned using a Typhoon 9410 scanner (GE Healthcare, NJ) with a resolution of 50 μm. 
Spot detection was performed on the gel images using the DeCyder 6.5 software. Before the 
matching process, up to 20 landmarks were defined all over the gel. After a match, the cycle of 
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reviewing and confirming the matches and re-matching was repeated manually until no new 
level 1 mismatches were found. The differences between the two groups were analyzed by t-test, 
which is provided by Decyder 6.5. The gels containing non-labeled protein were stained with 
Commassie blue for protein identification. The proteomics data were also filtered by using 1.5-
fold difference and a p-value less than 0.05 as a cutoff. Western blot analysis for some select 
proteins was tested to confirm the proteomics results (data not shown).  
 Lipidomics Analysis 
Phospholipid analysis was performed as described in our previous publications.
22,31
 In short, each 
frozen dorsal skin tissue was ground with liquid nitrogen. Then, 1 g of tissue was mixed with 2 
ml solvent [chloroform/methanol (1:2) + 0.01% butylated hydroxytoluene], an additional 1 ml of 
chloroform, and 1 ml of water. The mixture was centrifuged for 15 min at 1,000 rpm, and the 
lower layer was extracted. Another 1 ml of chloroform was added and the mixture was 
centrifuged as previously described, collecting the new lower layer. The two lower layer extracts 
were combined for phospholipid analysis using an automated ESI/MS-MS. Phospholipid 
analysis was able to determine phospholipid classes/subclasses such as Phosphatidic acid, PI, 
PC, lysoPC, alk(en)yl/acyl phosphocholine (ePC), PE, lysoPE, alk(en)yl/acyl 
phosphoethanolamine (ePE), phosphatidylserine (PS), alk(en)yl/acyl phosphoserine, 
sphingomyelin (SM), and ceramide PE. Phospholipid identification was based upon total 
mass/charge and fragment mass/charge consistent with the head group. 
Statistical Analysis  
Body weights were compared between treatment groups using one-way analysis of variance 
(ANOVA). Microarray and proteomics spots were considered statistically significant at 1.5-fold 
change using the student t-test with significance at p<0.05. Cytoscape v2.6.0 coupled with plug-
in BiNGO v2.0 was used for mapping the predominant gene ontology categories and the 
significantly altered genes were loaded into GenMAPP (Gene Map Annotator and Pathway 
Profiler, www.genmapp.org) to analyze the specific pathways. We also provide information on 
protein descriptions and biological pathways using Affymetrix NetAffx web site, GeneSpring, 
and GenMapp relevant software platforms and databases. Lipidomics analysis was performed 
18 
 
using one-way ANOVA and F test for significance, with pairwise comparison by the least 
significant difference method. 
 Results 
 Body Weight Change 
Body weight changes for the 13 weeks of the study are shown in Figure 2.1 (see below). The 
control group and AE groups demonstrated weight gains, at about 27 g final body weights at the 
end of the study. Both PE and DCR mice groups had significantly lower body weights of 
approximately 22 and 19 g, respectively, before sacrificing, demonstrating weight control.  Thus, 
DCR had the most pronounced weight loss, followed by PE. 
 
 
Figure 2.1  Body Weight changes. Data are shown for mice in the four groups: sedentary 
control (Control), ad-libitum exercise (AE), pair-fed exercise (PE), and dietary calorie 
restriction (DCR). Values are represented as mean  SE, n=13-17.  Means without a 
common letter differ, P<0.05. 
 Effect of Weight Loss on Gene Expression Profile 
Among 39,000 genes run, 411 transcripts by DCR, 67 transcripts by PE, and 110 transcripts by 
AE were significantly changed versus the control. The gene sets identified by microarray 
analysis that were significantly changed by weight control were further categorized using GO 
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annotations. The over represented GO categories were identified using BiNGO. Figure 2.2 (see 
below) shows the visualization of significantly changed gene network by Cytoscape. The 
shading of the node indicates the degree of statistical significance at black node > grey node > 
white node. There is an overall impact of gene change by DCR > PE > AE. In comparing the two 
weight control groups, DCR>PE in cancer genomic events related to cell homeostasis, cell 
growth, biological regulation and metabolic events such as primary and lipid metabolism. For the 
two exercise groups, PE>AE in cancer-related functions of cell death, cell differentiation, 
biological regulation, plasma membrane; however, cell metabolism genes changed little between 
PE and AE. DCR had distinctly more genetic changes in nearly all the GO categories as opposed 
to AE. Furthermore, Figure 2.3 (see next page) shows examples of the pathway analysis by 
GenMapp, indicating Raf MAP-Kinase pathway was significantly down-regulated by 0.64-fold 
and 0.66-fold change in PE and DCR groups, respectively, but upregulated by 1.55-fold in AE. 
 
Figure 2.2 BiNGO software representation showing which Gene Ontology (GO) sets of 
genes that are higher expressed in (A) AL+Exe Vs Control, (B) PF+Exe Vs Control, (C) 
DCR Vs Control. The coloring of the node indicates the statistical difference in gene 
expression of treatment group versus control (black node>grey node>white node) 
20 
 
 
Figure 2.3 The Hras-Braf MAP-Kinase pathway gene expression was visualized using 
GenMAPP software.  Gene expression is indicated as a ratio versus the control, and either 
up or down regulated (arrows). P<0.05. 
 
 Effect of Weight Loss on Protein Expression Profile 
We were able to identify ~120 proteins using proteomics and 22 proteins that were significantly 
changed by CyDye labeling. Table 2.2 (see next page) lists the 10 proteins that were up-
regulated and 12 proteins that were down-regulated by DCR. Some of the proteins had multiple 
spots including albumin (2), carbonic hydrase 3 (3), enolase 3:beta muscle (3), and ATP 
Synthase (H+ transporting, mitochondrial F1 complex) (2).   
 
21 
 
Table 2.2 Proteins that were up-regulated or down-regulated by Dietary Calorie 
Restriction (DCR) versus the Control utilizing a 2D-DlGE gel.
a   
 
Proteins Up-Regulated by DCR
b
 Proteins Down-Regulated by DCR
c
 
6-phosphogluconolactonase PDZ and LIM domain protein 
trisephosphate isomerase myosin light chain (phosphorytable) 
kininogen 1 precursor myosin A2 catalytic light chain 
albumin enolase 3: beta muscle 
ornithine aminotransferase gelsolin-like capping protein (capG) 
carbonic anhydrase 3 carbonic anhydrase 3 
apolipoprotein A-1 ATP Synthase (H+ transporting, F1) 
heat shock protein (cystallin related) aldose reductase 
Flavin reductase (NADPH-dependent) UGP2 protein 
peroxiredoxin 6 phosphoglycerate kinase 
 aconitase 2 
 adenylate kinase isoenzyme 1 
aProteins were scanned using a Typhoon 9410 scanner with resolution of 50 μm 
b
Up-regulated proteins had fold-change of ≥1.50, p<0.05 
c
Down-regulated proteins had fold-change of ≥1.50, p<0.05  
 
 Effect of Weight Loss on Phospholipid Expression Profile 
Among the 338 phospholipid species analyzed, 57 species were significantly changed by 
exercise. Compared to sedentary controls, most phosphatidylinositol (PI), ether 
phosphatidylcholine (ePC), and some lysophosphatidylcholine (lysoPC) molecular species 
decreased significantly in exercise with pair feeding mice. It should be noted that five PI groups 
decreased in isocaloric exercise PE as opposed to ad libitum feeding (AE). Figure 2.4 (see next 
page) illustrates five PI species that were significantly decreased in PE. 
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Figure 2.4 Molar percentage of phosphatidylinositol species between DCR, PE, and control 
as seen through ESI/MS-MS.  Values are shown as mean±SE, p<0.05, n=8-15. Letters 
indicate higher mol% of each lipid species amongst the treatment groups (a>b). 
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 Discussion 
Identical twin studies have identified cancer risk due to genetics at a rate of 
approximately 5-10%, thus emphasizing the importance of environmental factors such as those 
leading to obesity and its pro-cancer effect.
23
 This study demonstrated that both DCR and PE 
were effective in significantly lowering body weight as compared to the control, with DCR 
having the most impact on body weight. Weight loss in isocaloric exercise (PE) was not as 
pronounced as 20% DCR, possibly because the exercise was not strenuous enough to reach 20% 
calories burned in exercise.
14
 It appears that excess food intake in the ad-libitum group is 
responsible for the increased body weight that was comparable to the sedentary control group 
body weights. Meanwhile, AE was not able to reduce body weight and had similar weight levels 
to the control. It seems that exercise alone is not able to contribute to weight loss and its cancer 
preventive effect. Thus, DCR and isocaloric exercise (PE) were effective in reducing body 
weight for potential cancer prevention. 
Out of the 39,000 transcripts measured, 411 genes were changed by DCR, 67 genes by 
PE, and 110 genes by PE, illustrating the largest total number of genes changed occurred through 
DCR. To better grasp the specific molecular targets of DCR, BiNGO software was employed to 
analyze gene functions such as cellular components and regulations of biological processes like 
apoptosis, cell proliferation, and cell differentiation. DCR had the most change in functions 
related to cellular components and biological processes, while PE demonstrated moderate change 
in these functions versus AE. There was a progressive increase in gene change by treatment 
groups (DCR > PE > AE). While both DCR and PE modulated weight control, the genetic 
response shows a major distinction between DCR and PE. Cellular proliferation and anti-
apoptosis genes were decreased in both DCR and PE, with many genes related to MAPK and 
PI3K activity. DCR fostered more pronounced protection in genes related to these pro-cancer 
pathways. For example, insulin-like growth factor binding protein 3 reduces IGF-1 and cancer 
activity, and it was reduced by 1.89-fold change in PE and 2.50-fold change in DCR.  In looking 
for specific cellular pathways, we utilized GenMAPP software to identify specific pathways that 
are changed by diet. DCR and PE both reduced the Braf/MAPK pathway towards cell 
proliferation, whereas this pathway was up-regulated by AE. Braf/MAPK pathway is a cellular 
pathway towards increased cell proliferation that has been shown to be a mechanism for cancer 
promotion. It appears that PE has better genomic expression similar to DCR that is not mimicked 
24 
 
by AE.
21
 Additionally, DCR shows a unique metabolism genomic response as compared to the 
two exercise groups. DCR demonstrated the lowest body weight, and the noted change in 
metabolism-related genes provides an in vivo response that correlates with the phenotype of 
body weight change. This change of metabolism-related genes may provide not only insight into 
what negative energy balance affects but also indicator of how negative energy balance acts. 
While further studies need to be done to elucidate how DCR’s gene ontology differs from PE, it 
appears that both down-regulate the TPA-induced Ras-MAPK pathway. 
 Using 2D DIGE proteomics, we identified near 120 proteins. Among these proteins 
identified, we found that 22 proteins were significantly changed in DCR versus the control. The 
cancer-related functions of the proteins analyzed showed common functions such as energy 
metabolism/glycolysis and cellular stress responses. In analyzing the data, we identified proteins 
that may be key targets for cancer prevention and promotion such as Apolipoprotein A-1 
(APOA1) that was up-regulated by DCR (Table 2.2). APOA1 has been studied extensively for its 
cancer protective properties through reducing inflammation.
24
 Over-expression of APOA1 
mimetic peptides was associated with increased survival rates and inhibition of size and number 
of tumors in a mouse ovarian cancer model. APOA1 may foster cancer protection via binding 
lysophosphatidic acid (LPA), a proinflammatory lipoprotein that leads to cellular proliferation 
through the Ras-Rho GTPase crosstalk towards cancer promotion.
24,25
 This anti-activity of 
APOA1 on Ras-MAPK pathway provides a possible link between cancer prevention observed in 
microarray and proteomics data. Finally, oxidized phospholipids contribute to pro-
inflammation,
26
 and it is postulated that APOA1 may reduce this inflammatory response and 
exert pro-cancer effect through reducing MAPK activity.
24
 In contrast, gelsolin-like capping 
protein (capG), was an oncogenic protein that was down-regulated by DCR for cancer 
prevention. Bahassi et al. demonstrated that capG is important for tumor cell motility and cell 
proliferation, and they believe that down-regulation of capG by AP-1 transcription factor 
complex leads to cancer prevention.
27
 Increased cell motility in cancer has been shown to be 
correlated with increased Ras-MAPK activity,
25
 and the downregulation of capG may aid in 
DCR’s cancer prevention. Thus, it appears that DCR decreases pathways towards cancer 
promotion including Ras-MAPK and PI3K-Akt pathways, reduction of inflammation, and 
modulation of phospholipids by DCR for cancer prevention.
22
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Cancer prevention was further demonstrated through reduction of PI phospolipid species 
via PE treatment. Our lipidomics data indicated that weight control through PE reduced 5 PI 
species as opposed to the AE and control groups. The predominant form of PI in mouse tissue is 
PI 38:4.
22,28
 PI species can be a substrate of PI3K for cellular signaling pathway towards 
increased cancer promotion via downstream PI3K-Akt signaling. This decrease in PI 
phospholipids is consistent with previous research that indicates that PIs are decreased in 
exercised groups.
14
 PE had the most pronounced reduction in PI substrates compared to AE or 
the control. Our lab has also shown that exercise-induced reduction in PI phospholipids leads to 
protection from further downstream cancer promoting events through PI3K-related signaling.
22
   
A major hormone decreased for downstream reduction in this PI signaling is IGF-1, 
which is higher in excess fat/obese conditions and lower in weight controlled mice by DCR or 
exercise.
29,30
 In iso-caloric intake exercise-trained mice, our lab showed that IGF-1 restoration 
reversed the reduction of PI phospholipids and PI-associated PI3K down-expression for cancer 
prevention.
31
 Hence, it appears that IGF-1 is a required growth factor that promotes cancer 
etiology in overweight conditions, in part through promoting PI phosphorylation by PI3K and 
downstream Akt activity towards anti-apoptosis.
30,32
 Through demonstrating that PIs decreased 
in the phospholipid membrane, our study helps to better understand the mechanism for IGF-1 
reduction and inactivated PI3K-Akt activity. Morimura et al. demonstrated that IGF-1 promotes 
colocalization of IGF-1 receptor and PIP3, which is phosphorylated PIs by PI3K.
33
 This 
colocalization of IGF-1 receptor and phosphorylated PIs could explain how PIs could amplify 
the signal for anti-apoptosis from IGF-1. Reduced IGF-1 could lead to reduced localization of 
PIs and subsequent reduction of downstream signaling towards PI3K-Akt and anti-apoptosis.  
Figure 2.5 illustrates the possible mechanism through which weight control could lead to reduced 
IGF-1, PI3K activity, and anti-apoptosis. Thus, our phospholipidomics data further illustrates 
weight control’s important cancer prevention mechanism through the PI3K-Akt pathway. 
Although there are many other impacts that have not been figured out yet, it seems that 
cellular signaling pathways of Ras-MAPK and PI3K-Akt are the key cancer preventive targets 
that have been consistently demonstrated by three bioinformatics approaches. A possible 
limitation, for example, is that proteomics analysis did not detect many proteins especially for 
protein kinases. A more recently developed technique of phosphoproteomics may aid in 
identifying more kinases related to signaling pathways. 
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Taken together, this study identified PI3K-Akt and Ras-MAPK as two major pathways 
related to weight control and cancer prevention seen through all three bioinformatics approaches. 
Microarray data showed that the Ras-MAPK pathway was down-expressed in DCR and PE, but 
increased in AE. Our proteomics data showed that APOA1 and capG are proteins that are 
modified for cancer prevention by Ras-MAPK. APOA1 leads to a decrease in proinflammatory 
response that may be helpful for cancer prevention through modulating Ras-MAPK. CapG was 
also a protein reduced by DCR that is indicative of reduced Ras-MAPK and PI3K-Akt activity. 
Finally, lipidomics data showed reduced levels of PI species with isocaloric exercise (PE), 
suggesting how weight control can reduce the PI3K-Akt pathway towards anti-apoptosis. The 
three areas of bioinformatics utilized give us a more global overview for the protective effect of 
weight control through both isocaloric exercise and calorie restriction on cancer prevention. It 
seems that weight control helps to prevent against cancer through reduction in hormones such as 
IGF-1 and cross-talk between IGF-1-dependent and TPA-induced downstream signaling as 
concluded in Figure 2.5. 
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Figure 2.5 Overview of the study illustrating the molecular pathway through which weight 
control leads to cancer prevention. 
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